PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.51%
Revenue growth above 1.5x AR's 1.91%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
3.37%
Positive gross profit growth while AR is negative. John Neff would see a clear operational edge over the competitor.
28.63%
Positive EBIT growth while AR is negative. John Neff might see a substantial edge in operational management.
28.63%
Positive operating income growth while AR is negative. John Neff might view this as a competitive edge in operations.
165.94%
Positive net income growth while AR is negative. John Neff might see a big relative performance advantage.
167.80%
Positive EPS growth while AR is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
167.80%
Positive diluted EPS growth while AR is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.12%
Share reduction while AR is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.16%
Reduced diluted shares while AR is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
7.28%
Dividend growth of 7.28% while AR is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
3.25%
OCF growth under 50% of AR's 72.75%. Michael Burry might suspect questionable revenue recognition or rising costs.
9.29%
FCF growth under 50% of AR's 137.37%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
-83.85%
Negative 10Y revenue/share CAGR while AR stands at 1286.30%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-6.77%
Negative 5Y CAGR while AR stands at 369.55%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-18.00%
Negative 3Y CAGR while AR stands at 54.93%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-82.83%
Negative 10Y OCF/share CAGR while AR stands at 342.91%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-15.24%
Negative 5Y OCF/share CAGR while AR is at 303.86%. Joel Greenblatt would question the firm’s operational model or cost structure.
-38.34%
Negative 3Y OCF/share CAGR while AR stands at 29.19%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
28.60%
Positive 10Y CAGR while AR is negative. John Neff might see a substantial advantage in bottom-line trajectory.
126.34%
5Y net income/share CAGR similar to AR's 125.40%. Walter Schloss might see both on parallel mid-term trajectories.
106.90%
Positive short-term CAGR while AR is negative. John Neff would see a clear advantage in near-term profit trajectory.
-72.96%
Negative equity/share CAGR over 10 years while AR stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
8.36%
Below 50% of AR's 313.59%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-44.46%
Negative 3Y equity/share growth while AR is at 28.37%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-96.04%
Cut dividends over 10 years while AR stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-92.33%
Negative 5Y dividend/share CAGR while AR stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-69.21%
Negative near-term dividend growth while AR invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
80.59%
Our AR growth while AR is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-100.00%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-1.03%
Negative asset growth while AR invests at 1.06%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.84%
BV/share growth above 1.5x AR's 0.51%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-2.33%
We’re deleveraging while AR stands at 1.60%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-10.83%
We cut SG&A while AR invests at 41.95%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.